Stephan Oertel

Stephan Oertel

UNVERIFIED PROFILE

Are you Stephan Oertel?   Register this Author

Register author
Stephan Oertel

Stephan Oertel

Publications by authors named "Stephan Oertel"

Are you Stephan Oertel?   Register this Author

19Publications

525Reads

33Profile Views

Rituximab plus chlorambucil as first-line treatment for chronic lymphocytic leukemia: Final analysis of an open-label phase II study.

J Clin Oncol 2014 Apr 17;32(12):1236-41. Epub 2014 Mar 17.

Peter Hillmen, Abraham Varghese, and Andy Rawstron, St James's Institute of Oncology; Dena Cohen, University of Leeds, Leeds; John G. Gribben, Barts and the London School of Medicine; Claire E. Dearden, Royal Marsden Hospital; Amit Nathwani, University College London, London; George A. Follows, Addenbrooke's Hospital, Cambridge; Donald Milligan, Heartlands Hospital, Birmingham; Hazem A. Sayala, Hull and East Yorkshire Hospitals, Hull; Paul Moreton, Pinderfields General Hospital, Wakefield; David G. Oscier, Royal Bournemouth Hospital, Bournemouth; Daniel B. Kennedy, Leicester Royal Infirmary, Leicester; Andrew R. Pettitt, Royal Liverpool and Broadgreen University Hospitals National Health Service Trust, Liverpool; Christopher F.E. Pocock, East Kent Hospitals, Canterbury, United Kingdom; and Stephan Oertel, F. Hoffmann-La Roche, Basel, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.49.6547DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876343PMC
April 2014

Successful long-term monotherapy with rituximab in a patient with chronic lymphocytic leukemia of the B-cell-lineage: a case report.

J Med Case Rep 2008 Aug 14;2:275. Epub 2008 Aug 14.

Department of Hematology and Oncology, Charité Campus Virchow-Klinikum, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1752-1947-2-275DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2531126PMC
August 2008

Rituximab in the management of post-transplantation lymphoproliferative disorder after solid organ transplantation: proceed with caution.

Ann Hematol 2007 Aug 24;86(8):599-607. Epub 2007 May 24.

Department of Hematology, Hôpital Pitié-Salpétrière, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-007-0298-2DOI Listing
August 2007

Quantitative analysis of EBV-specific CD4/CD8 T cell numbers, absolute CD4/CD8 T cell numbers and EBV load in solid organ transplant recipients with PLTD.

Transpl Immunol 2007 Apr 29;17(3):203-10. Epub 2006 Nov 29.

Charité-Universitaetsmedizin Berlin, Campus Virchow Klinikum, Med. Klinik m. S. Haematologie/Onkologie, D-13353 Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.trim.2006.10.006DOI Listing
April 2007

Epstein-Barr viral load in whole blood of adults with posttransplant lymphoproliferative disorder after solid organ transplantation does not correlate with clinical course.

Ann Hematol 2006 Jul 4;85(7):478-84. Epub 2006 Apr 4.

Department of Hematology and Oncology, Charite-Universitätsmedizin Berlin, Campus Virchow Klinikum, Augustenburger Platz 1, 13353, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-006-0109-1DOI Listing
July 2006

Effective use of high-dose chemotherapy and autologous stem cell rescue for relapsed adult Wilms' tumor and a novel alteration in intron 1 of the WT1 gene.

J Pediatr Hematol Oncol 2004 Dec;26(12):820-3

Department of Hematology and Oncology, Charité University Hospital Berlin, Campus Virchow Klinikum, Augustenburger Platz 1, D-13353 Berlin, Germany.

View Article

Download full-text PDF

Source
December 2004

Identification of early antigen BZLF1/ZEBRA protein of Epstein-Barr virus can predict the effectiveness of antiviral treatment in patients with post-transplant lymphoproliferative disease.

Br J Haematol 2002 Sep;118(4):1120-3

Hämatologie und Onkologie, Universitätsklinikum Charite-Campus Virchow, Humboldt-Universität Berlin, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1046/j.1365-2141.2002.03764.xDOI Listing
September 2002

Immunosurveillance, immunodeficiency and lymphoproliferations.

Recent Results Cancer Res 2002 ;159:1-8

Hämatologie und Onkologie, Humboldt-Universität Berlin, Charité Campus Virchow-Klinikum, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-642-56352-2_1DOI Listing
June 2002

Antiviral treatment of Epstein-Barr virus-associated lymphoproliferations.

Recent Results Cancer Res 2002 ;159:89-95

Hämatologie und Onkologie, Humboldt-Universität Berlin, Charité Campus Virchow-Klinikum, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-642-56352-2_11DOI Listing
June 2002